TRIO Pharmaceuticals
Developer of a cancer immunotherapeutic antibody drug designed to generate immunogenic tumors. The company's drug offers dual-action tumor immunity-enhancing qualities aimed at treating cancers of hig...
Valuation
$17M
Latest known
Share Price
N/A
Total Raised
$8.5M
Last Round
N/A